Impact of gender on the safety profile of chemotherapy plus bevacizumab in mCRC: A pooled analysis of TRIBE and TRIBE2 studies.

Authors

null

Gemma Zucchelli

Department of Translational Research and New Technologies in Medicine and Surgery, Unit of Medical Oncology 2, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy

Gemma Zucchelli , Roberto Moretto , Marta Schirripa , Rossana Intini , Daniele Rossini , Daniele Santini , Claudio Pizzo , Carlotta Antoniotti , Beatrice Borelli , Federica Marmorino , Federica Urbano , Valentina Burgio , Michela Libertini , Michele Prisciandaro , Angela Buonadonna , Sara Bustreo , Giacomo Allegrini , Vincenzo Ricci , Chiara Cremolini , Alfredo Falcone

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Colorectal) Cancer

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Colorectal Cancer–Advanced Disease

Citation

J Clin Oncol 37, 2019 (suppl; abstr 3534)

DOI

10.1200/JCO.2019.37.15_suppl.3534

Abstract #

3534

Poster Bd #

26

Abstract Disclosures